Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study

CONCLUSION: A third dose of the COVID-19 vaccine was associated with a decreased risk of all-cause mortality among HD patients during the Omicron-dominant period. A higher post-vaccination anti-S protein RBD antibody level was also associated with a lower risk of mortality.PMID:37770324 | DOI:10.1016/j.jmii.2023.09.002

Source: Journal of Microbiology, Immunology, and Infection - September 28, 2023 Category: Microbiology Authors: Tz-Heng Chen Yang Ho Hsin-Ling Tai Yuan-Chia Chu Yao-Ping Lin Chih-Yu Yang Wei-Cheng Tseng Shuo-Ming Ou Ming-Tsun Tsai Jinn-Yang Chen Tsai-Hung Wu Kuo-Hua Lee Fan-Yu Chen Szu-Yuan Li Chih-Ching Lin Der-Cherng Tarng Source Type: research